Hpai-research Adam28,Blog,Drg1,Hyou1,Igfbp6,Itgae Biodetection of a specific odor signature in mallard feces associated with infection by low pathogenic avian influenza A virus

Biodetection of a specific odor signature in mallard feces associated with infection by low pathogenic avian influenza A virus

Outbreaks of avian influenza virus (AIV) an infection included the unfold of extremely pathogenic AIV in business poultry and yard flocks within the spring of 2015. This resulted in estimated losses of greater than $8.5 million from federal authorities expenditures, $1.6 billion from direct losses to produces arising from destroyed turkey and hen egg manufacturing, and economy-wide oblique prices of $3.Three billion from impacts on retailers and the meals service industries.
Moreover, these outbreaks resulted within the loss of life or depopulation of almost 50 million home birds. Domesticated male ferrets (Mustela putorius furo) had been educated to show a selected conditioned habits (i.e. energetic scratch alert) in response to feces from AIV-infected mallards compared to feces from wholesome geese. So as to set up that ferrets had been figuring out samples based mostly on odors related to an infection, extra experiments managed for probably confounding results, comparable to: particular person duck id, housing and feed, inoculation focus, and day of pattern assortment (post-infection).
A last experiment revealed that educated ferrets might detect AIV an infection standing even within the presence of samples from mallards inoculated with Newcastle illness virus or infectious laryngotracheitis virus. These outcomes point out that mammalian biodetectors are able to discriminating the particular odors emitted from the feces of non-infected versus AIV contaminated mallards, suggesting that the well being standing of waterfowl might be evaluated non-invasively for AIV an infection through monitoring of unstable fecal metabolites. Moreover, in situ monitoring utilizing educated biodetectors could also be an efficient device for assessing inhabitants well being.

H7N9 influenza virus-like particle based mostly on BEVS protects chickens from deadly problem with extremely pathogenic H7N9 avian influenza virus

H7N9 avian influenza virus poses a twin menace to each poultry trade and public well being. Subsequently, it’s extremely pressing to develop an efficient vaccine to scale back its pandemic potential. Virus-like particles (VLP) symbolize an efficient method for pandemic vaccine improvement. On this research, a recombinant baculovirus co-expressing the HA, NA and M1 genes of the H7N9 virus was constructed for era of H7N9 VLP. Single immunization of chickens with 15 μg of the VLP or the business complete virus inactivated vaccine stimulates excessive hemagglutination inhibition, virus neutralizing and HA-specific IgY antibodies. Furthermore, the antiserum had a great cross-reactivity with H7N9 discipline strains remoted in several years.
Inside 14 days after a deadly problem with extremely pathogenic (HP) H7N9 virus, no scientific signs and loss of life had been noticed within the vaccinated chickens, and no virus was recovered from the organs. In comparison with the non-vaccinated chickens, H7N9 VLP considerably decreased the proportion of animals shedding virus. Solely 30 % of the VLP-vaccinated birds shed virus, whereas virus shedding was detected in 50 % of the chickens immunized with the business vaccine.
Furthermore, each vaccines dramatically alleviated pulmonary lesions attributable to HP H7N9 virus, with a better diploma noticed for the VLP. Altogether, our outcomes indicated that the H7N9 VLP vaccine candidate confers an entire scientific safety towards a deadly problem with HP H7N9 virus, considerably inhibits virus shedding and abolishes viral replication in chickens. The VLP generated on this research represents a promising various technique for the event of novel H7N9 avian influenza vaccines for chickens.

Towards Growing Therapies towards Corona Virus: Synthesis and Anti-Avian Influenza Virus Exercise of Novel Cytosine Thioglycoside Analogues

A sequence of pyrimidine and pyrimidine thioglycoside derivatives had been newly synthesized utilizing sodium 2-cyano-3-(arylamino)prop-1-ene-1,1-bis(thiolates) and urea to offer the corresponding sodium 6-amino-5-aryl-2-oxo-1,2-dihydropyrimidine-4-thiolates. Stirring of the latter with peracetylated α-d-gluco- and galacto-pyranosyl bromides in DMF afforded the corresponding pyrimidine thioglycosides.
Alternatively, therapy of 6-amino-5-aryl-2-oxo-1,2-dihydropyrimidine-4-thiolate salts with hydrochloric acid produced the corresponding pyrimidine-4-thioles, which on stirring with α-d-gluco- and galacto-pyranosyl bromides in sodium hydride and DMF gave the corresponding pyrimidine thioglycosides. Deacetylation of the protected pyrimidine thioglycosides gave the corresponding free pyrimidine thioglycosides. The synthesized compounds have been characterised by 13C NMR, 1H NMR, and IR spectroscopy.
The pyrimidine thioglycosides and free pyrimidine thioglycosides had been examined towards avian influenza H5N1 virus pressure and exhibited highest to reasonable exercise.
Biodetection of a specific odor signature in mallard feces associated with infection by low pathogenic avian influenza A virus

Inhabitants genomic transformations induced by isolation of untamed fowl avian influenza viruses (Orthomyxoviridae) in embryonated hen eggs

Isolation and cultivation of wild-type viruses in mannequin organism cells or tissues is normal apply in virology. Oftentimes, the virus host species is distantly associated to the species from which the tradition system was developed. Thus, virus tradition in these tissues and cells principally constitutes a bunch leap, which might result in genomic modifications by means of genetic drift and/or adaptation to the tradition system.
We immediately sequenced 70 avian influenza virus (Orthomyxoviridae) genomes from oropharyngeal/cloacal swabs collected from wild fowl species and paired virus isolates propagated from the identical samples following isolation in specific-pathogen-free embryonated hen eggs. The info had been analyzed utilizing inhabitants genetic approaches together with analysis of single nucleotide polymorphism (SNP) frequencies and divergence with pooled-sequencing analyses, consensus sequence placement in neighbor-joining bushes, and haplotype reconstruction and networks.
We discovered that propagation of virus in eggs results in skewed SNP mutation spectra with some SNPs going to fixation. Each synonymous and nonsynonmous SNP frequencies shifted. We discovered a number of consensus sequences that differed between the swabs and the isolates, with some sequences from the identical pattern falling into divergent genetic clusters.
Twenty of 23 coinfections detected had totally different dominant subtypes following virus isolation, thus sequences from each the swab and isolate had been wanted to acquire full subtype information. Haplotype networks revealed haplotype frequency shifts and the looks or lack of low-frequency haplotypes following isolation. The outcomes from this research revealed that isolation of untamed fowl avian influenza viruses in hen eggs results in skewed populations which might be totally different than the enter populations.
Consensus sequence modifications from virus isolation can result in flawed phylogenetic inferences, and subtype detection is biased. These outcomes recommend that for genomic research of untamed fowl influenza viruses the organic discipline ought to transfer away from hen egg isolation in the direction of immediately sequencing the virus from host samples.

Utilizing geospatial strategies to measure the danger of environmental persistence of avian influenza virus in South Carolina

Avian influenza (AIV) is a extremely contagious virus that may infect each wild birds and home poultry. This research aimed to outline areas inside the state of South Carolina (SC) at heightened threat for environmental persistence of AIV utilizing geospatial strategies. Environmental elements identified to affect AIV survival had been recognized by means of the printed literature and utilizing a multi-criteria choice evaluation with GIS was carried out.

Avian Influenza Hemagglutinin Peptide

MBS153184-5x005mg 5x0.05mg
EUR 770

Avian Influenza Hemagglutinin Peptide

PM-4005P 0.05 mg
EUR 99

Avian Influenza Hemagglutinin Peptide

PM-4006P 0.05 mg
EUR 99

Avian Influenza Hemagglutinin 2 Peptide

3909P 0.05 mg
EUR 197.7
Description: (NT) Avian Influenza Hemagglutinin 2 peptide

Avian Influenza Hemagglutinin 3 Peptide

3911P 0.05 mg
EUR 197.7
Description: (IN) Avian Influenza Hemagglutinin 3 peptide

Avian Influenza Hemagglutinin 4 Peptide

3913P 0.05 mg
EUR 197.7
Description: (IN) Avian Influenza Hemagglutinin 4 peptide

Avian Influenza Hemagglutinin 2 Peptide

MBS152500-005mg 0.05mg
EUR 175

Avian Influenza Hemagglutinin 2 Peptide

MBS152500-5x005mg 5x0.05mg
EUR 770

Avian Influenza Hemagglutinin 3 Peptide

MBS152685-005mg 0.05mg
EUR 175

Avian Influenza Hemagglutinin 3 Peptide

MBS152685-5x005mg 5x0.05mg
EUR 770

Avian Influenza Hemagglutinin 4 Peptide

MBS153045-005mg 0.05mg
EUR 175

Avian Influenza Hemagglutinin 4 Peptide

MBS153045-5x005mg 5x0.05mg
EUR 770

Avian Influenza Hemagglutinin 3 Peptide

PM-4007P 0.05 mg
EUR 99

Avian Influenza Hemagglutinin 3 Peptide

PM-4008P 0.05 mg
EUR 99

Avian Influenza Hemagglutinin 3 Peptide

PM-4009P 0.05 mg
EUR 99

Avian Influenza A H7N9 Hemagglutinin Peptide

7821P 0.05 mg
EUR 197.7
Description: (IN) Avian Influenza A H7N9 Hemagglutinin Peptide

Avian Influenza A H7N9 Hemagglutinin Peptide

7823P 0.05 mg
EUR 197.7
Description: (IN) Avian Influenza A H7N9 Hemagglutinin Peptide

Avian Influenza A H7N9 Hemagglutinin Peptide

7825P 0.05 mg
EUR 197.7
Description: (IN) Avian Influenza A H7N9 Hemagglutinin Peptide

Avian Influenza A H7N9 Hemagglutinin Peptide

MBS154004-005mg 0.05mg
EUR 175

Avian Influenza A H7N9 Hemagglutinin Peptide

MBS154004-5x005mg 5x0.05mg
EUR 770

Avian Influenza A H7N9 Hemagglutinin Peptide

MBS154019-005mg 0.05mg
EUR 175

Avian Influenza A H7N9 Hemagglutinin Peptide

MBS154019-5x005mg 5x0.05mg
EUR 770

Avian Influenza A H7N9 Hemagglutinin Peptide

MBS154155-005mg 0.05mg
EUR 175

Avian Influenza A H7N9 Hemagglutinin Peptide

MBS154155-5x005mg 5x0.05mg
EUR 770

Influenza A H5N1 (Avian) Hemagglutinin, N-Terminal Peptide

11-559 0.05 mg
EUR 645
Description: Influenza A H5N1 (Avian) Hemagglutinin, N-Terminal Peptide

Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide

11-557 0.05 mg
EUR 632.4
Description: Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide

Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide

11-558 0.05 mg
EUR 645
Description: Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide

MBS633819-005mg 0.05mg
EUR 880

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide

MBS633819-5x005mg 5x0.05mg
EUR 3820

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN), Control Peptide

MBS658813-005mg 0.05mg
EUR 700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN), Control Peptide

MBS658813-5x005mg 5x0.05mg
EUR 2990

Avian Influenza Hemagglutinin 1 Antibody

24454 100ul
EUR 479

Avian Influenza Hemagglutinin 1 Antibody

24454-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin 1 Antibody

MBS151143-01mg 0.1mg
EUR 445

Avian Influenza Hemagglutinin 1 Antibody

MBS151143-5x01mg 5x0.1mg
EUR 1965

Avian Influenza Hemagglutinin 1 Antibody

MBS9410662-01mL 0.1mL
EUR 495

Avian Influenza Hemagglutinin 1 Antibody

MBS9410662-5x01mL 5x0.1mL
EUR 2075

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide (Bird Flu)

MBS658994-005mg 0.05mg
EUR 395

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide (Bird Flu)

MBS658994-5x005mg 5x0.05mg
EUR 1630

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) Control Peptide (Bird Flu)

MBS659545-005mg 0.05mg
EUR 395

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) Control Peptide (Bird Flu)

MBS659545-5x005mg 5x0.05mg
EUR 1630

Avian Influenza Hemagglutinin Antibody

3425-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza Hemagglutinin Antibody

3425-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza Hemagglutinin Antibody

3427-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza Hemagglutinin Antibody

3427-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza Hemagglutinin Antibody

24276 100ul
EUR 479

Avian Influenza Hemagglutinin Antibody

24276-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin Antibody

24277 100ul
EUR 479

Avian Influenza Hemagglutinin Antibody

24277-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin Antibody

MBS151256-01mg 0.1mg
EUR 445

Avian Influenza Hemagglutinin Antibody

MBS151256-5x01mg 5x0.1mg
EUR 1965

Avian Influenza Hemagglutinin Antibody

MBS150485-01mg 0.1mg
EUR 445

Avian Influenza Hemagglutinin Antibody

MBS150485-5x01mg 5x0.1mg
EUR 1965

Avian Influenza Hemagglutinin Antibody

MBS9401705-01mL 0.1mL
EUR 495

Avian Influenza Hemagglutinin Antibody

MBS9401705-5x01mL 5x0.1mL
EUR 2075

Avian Influenza Hemagglutinin Antibody

MBS9404745-01mL 0.1mL
EUR 495

Avian Influenza Hemagglutinin Antibody

MBS9404745-5x01mL 5x0.1mL
EUR 2075

Avian Influenza Hemagglutinin 2 Antibody

24449 100ul
EUR 479

Avian Influenza Hemagglutinin 2 Antibody

24449-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin 3 Antibody

24450 100ul
EUR 479

Avian Influenza Hemagglutinin 3 Antibody

24450-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin 4 Antibody

24451 100ul
EUR 479

Avian Influenza Hemagglutinin 4 Antibody

24451-100ul 100ul
EUR 468

Avian Influenza A Hemagglutinin Antibody

GWB-68DB90 0.1 mg Ask for price

Avian Influenza Hemagglutinin 3 Antibody

MBS151039-01mg 0.1mg
EUR 445

Avian Influenza Hemagglutinin 3 Antibody

MBS151039-5x01mg 5x0.1mg
EUR 1965

Avian Influenza Hemagglutinin 4 Antibody

MBS151450-01mg 0.1mg
EUR 445

Avian Influenza Hemagglutinin 4 Antibody

MBS151450-5x01mg 5x0.1mg
EUR 1965

Avian Influenza Hemagglutinin 2 Antibody

MBS150283-01mg 0.1mg
EUR 445

Avian Influenza Hemagglutinin 2 Antibody

MBS150283-5x01mg 5x0.1mg
EUR 1965

Avian Influenza Hemagglutinin 3 Antibody

MBS9404749-01mL 0.1mL
EUR 495

Avian Influenza Hemagglutinin 3 Antibody

MBS9404749-5x01mL 5x0.1mL
EUR 2075

Avian Influenza Hemagglutinin 4 Antibody

MBS9404916-01mL 0.1mL
EUR 495

Avian Influenza Hemagglutinin 4 Antibody

MBS9404916-5x01mL 5x0.1mL
EUR 2075

Avian Influenza Hemagglutinin 2 Antibody

MBS9408563-01mL 0.1mL
EUR 495

Avian Influenza Hemagglutinin 2 Antibody

MBS9408563-5x01mL 5x0.1mL
EUR 2075

Influenza Hemagglutinin Peptide

463888 1.0mg
EUR 230

Influenza Hemagglutinin (HA) Peptide

A6004-25 25 mg
EUR 312
Description: Tag Peptides

Influenza Hemagglutinin (HA) Peptide

A6004-5 5 mg
EUR 79.2
Description: Tag Peptides

Influenza Hemagglutinin (HA) Peptide

A6004-5.1 10 mM (in 1mL DMSO)
EUR 160
Description: Tag Peptides

Influenza Hemagglutinin (HA) Peptide

MBS385481-10mg 10mg
EUR 230

Influenza Hemagglutinin (HA) Peptide

MBS385481-25mg 25mg
EUR 465

Influenza Hemagglutinin (HA) Peptide

MBS385481-5mg 5mg
EUR 165

Influenza Hemagglutinin (HA) Peptide

MBS385481-5x25mg 5x25mg
EUR 2080

Influenza A, Avian, H6N1, Hemagglutinin (HA)

MBS645330-01mg 0.1mg
EUR 650

Influenza A, Avian, H6N1, Hemagglutinin (HA)

MBS645330-5x01mg 5x0.1mg
EUR 2765

Influenza A, Avian, H6N1, Hemagglutinin (HA)

MBS6006346-01mg 0.1(mg
EUR 680

Influenza A, Avian, H6N1, Hemagglutinin (HA)

MBS6006346-5x01mg 5x0.1mg
EUR 2920

Avian Influenza H5N1 Hemagglutinin (NT) Antibody

3909-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin 2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (NT) Antibody

3909-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin 2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza A H7N9 Hemagglutinin Antibody

7821-002mg 0.02 mg
EUR 206.18
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

Avian Influenza A H7N9 Hemagglutinin Antibody

7821-01mg 0.1 mg
EUR 523.7
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

Avian Influenza A H7N9 Hemagglutinin Antibody

7823-002mg 0.02 mg
EUR 206.18
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

Avian Influenza A H7N9 Hemagglutinin Antibody

7823-01mg 0.1 mg
EUR 523.7
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

Avian Influenza A H7N9 Hemagglutinin Antibody

7825-002mg 0.02 mg
EUR 206.18
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

Avian Influenza A H7N9 Hemagglutinin Antibody

7825-01mg 0.1 mg
EUR 523.7
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

Avian Influenza A H7N9 Hemagglutinin Antibody

MBS153473-01mg 0.1mg
EUR 445

Avian Influenza A H7N9 Hemagglutinin Antibody

MBS153473-5x01mg 5x0.1mg
EUR 1965

Avian Influenza A H7N9 Hemagglutinin Antibody

MBS153575-01mg 0.1mg
EUR 445

Avian Influenza A H7N9 Hemagglutinin Antibody

MBS153575-5x01mg 5x0.1mg
EUR 1965

Avian Influenza A H7N9 Hemagglutinin Antibody

MBS153697-01mg 0.1mg
EUR 445

Avian Influenza A H7N9 Hemagglutinin Antibody

MBS153697-5x01mg 5x0.1mg
EUR 1965

Avian Influenza H5N1 Hemagglutinin (IN1) Antibody

3911-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin 3 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (IN1) Antibody

3911-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin 3 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (IN2) Antibody

3913-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin 4 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (IN2) Antibody

3913-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin 4 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (IN3) Antibody

3925-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin 1 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (IN3) Antibody

3925-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin 1 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Influenza A H5N1 Hemagglutinin Peptide

abx060606-005mg 0.05 mg
EUR 828

Influenza A H5N1 Hemagglutinin Peptide

abx060606-100g 100 µg Ask for price

Influenza A H5N1 Hemagglutinin Peptide

abx060606-10g 10 µg
EUR 537.5

Influenza A H5N1 Hemagglutinin Peptide

abx060606-50g 50 µg Ask for price

Influenza PR8 Hemagglutinin Peptide (110-119)

H-6312.0005 5.0mg
EUR 327.6
Description: Sum Formula: C63H90N14O16; CAS# [132031-50-6] net

Influenza PR8 Hemagglutinin Peptide (110-119)

H-6312.0025 25.0mg
EUR 1197.6
Description: Sum Formula: C63H90N14O16; CAS# [132031-50-6] net

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00117 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00129 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00130 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00153 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00154 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00155 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00156 1 mg Ask for price

Influenza Antibody (A Hemagglutinin H5) (Avian H5N1)

GWB-T00157 1 mg Ask for price

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS632056-01mg 0.1mg
EUR 1200

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS632056-5x01mg 5x0.1mg
EUR 5245

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS609588-01mg 0.1mg
EUR 680

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS609588-5x01mg 5x0.1mg
EUR 2910

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS608939-1mg 1mg
EUR 1070

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS608939-5x1mg 5x1mg
EUR 4660

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS609096-02mg 0.2mg
EUR 725

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS609096-5x02mg 5x0.2mg
EUR 3100

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS609150-01mg 0.1mg
EUR 680

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu)

MBS609150-5x01mg 5x0.1mg
EUR 2910

Polyclonal Avian Influenza A H7N9 Hemagglutinin Antibody

APR10994G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Hemagglutinin . This antibody is tested and proven to work in the following applications:

Polyclonal Avian Influenza A H7N9 Hemagglutinin Antibody

APR10995G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Hemagglutinin . This antibody is tested and proven to work in the following applications:

Polyclonal Avian Influenza A H7N9 Hemagglutinin Antibody

APR10996G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Hemagglutinin . This antibody is tested and proven to work in the following applications:

Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag

REC31991-100 0.1
EUR 301.29
Description: Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein.

Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag

REC31991-500 0.5
EUR 1057.09
Description: Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein.

Hemagglutinin (48-68) / Influenza virus Peptide

abx266859-1ml 1 ml
EUR 475

Hemagglutinin (48-68) / Influenza virus Peptide

abx266859-200l 200 µl
EUR 225

Hemagglutinin (48-68) / Influenza Virus Peptide

PE-88515
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg
  • 10 mg

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS632337-01mg 0.1mg
EUR 635

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS632337-5x01mg 5x0.1mg
EUR 2700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS632515-01mg 0.1mg
EUR 635

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS632515-5x01mg 5x0.1mg
EUR 2700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS630004-01mg 0.1mg
EUR 635

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS630004-5x01mg 5x0.1mg
EUR 2700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) (Bird Flu)

MBS629237-01mg 0.1mg
EUR 635

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) (Bird Flu)

MBS629237-5x01mg 5x0.1mg
EUR 2700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (PE)

MBS6251929-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (PE)

MBS6251929-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (AP)

MBS6248038-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (AP)

MBS6248038-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS609567-01mg 0.1mg
EUR 855

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS609567-5x01mg 5x0.1mg
EUR 3685

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS633077-01mg 0.1mg
EUR 855

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS633077-5x01mg 5x0.1mg
EUR 3685

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS631658-01mg 0.1mg
EUR 635

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu)

MBS631658-5x01mg 5x0.1mg
EUR 2700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (HRP)

MBS6250975-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (HRP)

MBS6250975-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (APC)

MBS6268892-01mL 0.1mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (APC)

MBS6268892-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (FITC)

MBS6249976-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (FITC)

MBS6249976-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (Biotin)

MBS6249053-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (Biotin)

MBS6249053-5x01mL 5x0.1mL
EUR 4405

Influenza A H5N1 (Avian Flu) Hemagglutinin Antibody Pair Set

ABPR-ZB322 5 plates, 15 plates Ask for price
Description: Quantitative determination of H5N1 Hemagglutinin

Influenza A H5N1 (Avian Flu) Hemagglutinin/HA ELISA Pair Set

MBS8119620-15Plates 15Plates
EUR 780

Influenza A H5N1 (Avian Flu) Hemagglutinin/HA ELISA Pair Set

MBS8119620-5Plates 5Plates
EUR 425

Influenza A H5N1 (Avian Flu) Hemagglutinin/HA ELISA Pair Set

MBS8119620-5x15Plates 5x15Plates
EUR 3360

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 405)

MBS6252947-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 405)

MBS6252947-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 490)

MBS6253987-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 490)

MBS6253987-5x01mL 5x0.1mL
EUR 4405

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 550)

MBS6255027-01mL 0.1(mL
EUR 1010

Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 550)

MBS6255027-5x01mL 5x0.1mL
EUR 4405
Threat was outlined utilizing 5 classes following the World Group for Animal Well being Threat Evaluation Tips. Lower than 1% of 1km grid cells in SC confirmed a excessive threat of AIV persistence. Roughly 2% – 17% of counties with excessive or very excessive environmental threat additionally had medium to very excessive numbers of economic poultry operations. Outcomes can be utilized to enhance surveillance actions and to tell biosecurity practices and emergency preparedness efforts.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post